Surgery for Obesity and Related Diseases
Volume 6, Issue 1 , Pages 36-40, January 2010

Peroral endoscopic anastomotic reduction improves intractable dumping syndrome in Roux-en-Y gastric bypass patients

  • Gloria Fernández-Esparrach, M.D., Ph.D.

      Affiliations

    • Department of Medicine, Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts
  • ,
  • David B. Lautz, M.D.

      Affiliations

    • Department of Surgery, Division of General and Gastrointestinal Surgery, Brigham and Women's Hospital, Boston, Massachusetts
  • ,
  • Christopher C. Thompson, M.D., M.Sc., F.A.C.G., F.A.S.G.E.

      Affiliations

    • Department of Medicine, Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Christopher C. Thompson, MD, MSc, FACG, FASGE, Division of Developmental Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115

Received 27 September 2008; received in revised form 6 April 2009; accepted 8 April 2009. published online 24 April 2009.

Abstract 

Background

Dumping syndrome is a well-described consequence of Roux-en-Y gastric bypass. Although the condition can benefit some patients with morbid obesity, a subset will develop intractable dumping syndrome characterized by symptomatic episodes with most meals. We describe the first series of patients successfully treated endoscopically for intractable dumping syndrome.

Methods

Endoscopic gastrojejunal anastomotic reduction was performed in patients with intractable dumping syndrome after Roux-en-Y gastric bypass using a combination of argon plasma coagulation, endoscopic suturing, and fibrin glue. The technical feasibility of endoscopic anastomotic reduction and the clinical improvement in dumping symptoms were assessed by clinical follow-up.

Results

Endoscopic anastomotic reduction was technically successful in 6 consecutive patients with a dilated gastrojejunal anastomosis and intractable dumping syndrome. One patient reported hematemesis 2 days after the procedure that was treated endoscopically. No other significant complications occurred. Complete and persistent resolution of the dumping symptoms was achieved in all patients, with a median follow-up of 636 days.

Conclusion

Endoscopic anastomotic reduction appears technically feasible and safe and might be a minimally invasive treatment option for patients who experience intractable dumping symptoms after Roux-en-Y gastric bypass. Additional studies are needed to determine the long-term efficacy of this procedure.

Keywords: Dumping syndrome, Endoscopic anastomotic reduction, Gastric bypass, Morbid obesity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 G. Fernández-Esparrach is currently at Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIPAPS), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.

PII: S1550-7289(09)00362-1

doi:10.1016/j.soard.2009.04.002

Surgery for Obesity and Related Diseases
Volume 6, Issue 1 , Pages 36-40, January 2010